Opportunities in the pharmaceutical API manufacturing market include leveraging rising demand for complex biologics, ...
BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today reported strong growth in 2022 in both its ...
The market offers growth opportunities driven by increased demand for personalized medicine, advancements in cell and gene ...
BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...
Rising API prices from China and feedstock disruptions amid the West Asia crisis are tightening cost pressures on India's ...
C2 Pharma, which concentrates on hard-to-make ingredients, has picked up a new supply of digoxin. The deal will give it two supplies of API for making the sometimes-difficult-to-get drug. The ...
Vion Pharmaceuticals Extends Agreement With SAFC Pharma Partnership for Cloretazine API Manufacturing ST. LOUIS, March 21 -- SAFC, a member of the Sigma-Aldrich Group, continues its appointment as a ...
On April 22, 2026, the U.S. Department of Justice and Drug Enforcement Administration’s final order rescheduling FDA-approved cannabis drug ...
ST Pharm, a specialized contract development and manufacturing organization (CDMO) subsidiary of Dong-A Socio Holdings, said on the 16th that it signed a contract to supply active pharmaceutical ...
KD Pharma, a Swiss API maker of omega-3 products, has snapped up a manufacturing site in Seal Sands, U.K., for an undisclosed price. The company said the acquisition will allow it to expand capacity ...
BUFFALO, N.Y., Jan. 23, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results